QT
URGN icon

Quantbot Technologies’s UroGen Pharma URGN Stock Holding History

Quantbot Technologies’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.5K Buy
+2,133
New +$57.8K ﹤0.01% 1529
2026
Q1 		– Sell
-200
Closed -$4.68K – 2184
2025
Q4 		$4.68K Buy
+200
New +$4.34K ﹤0.01% 1623
2023
Q1 		– Sell
-706
Closed -$6.26K – 2096
2022
Q4 		$6.26K Sell
706
-200
-22% -$1.89K ﹤0.01% 1542
2022
Q3 		$7K Sell
906
-1,200
-57% -$9.93K ﹤0.01% 1457
2022
Q2 		$17K Buy
+2,106
New +$14.5K ﹤0.01% 1471
2021
Q4 		– Sell
-800
Closed -$13K – 1942
2021
Q3 		$13K Buy
+800
New +$12.7K ﹤0.01% 1328
2020
Q1 		– Sell
-1,455
Closed -$48K – 1412
2019
Q4 		$48K Sell
1,455
-1,283
-47% -$35K ﹤0.01% 959
2019
Q3 		$65K Buy
2,738
+1,238
+83% +$40.5K 0.01% 922
2019
Q2 		$53K Buy
+1,500
New +$55.3K 0.01% 886
2018
Q3 		– Sell
-3,687
Closed -$183K – 1565
2018
Q2 		$183K Buy
3,687
+169
+5% +$9.84K 0.01% 751
2018
Q1 		$174K Buy
+3,518
New +$176K 0.02% 727

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Quantbot Technologies's URGN Position: Q2 2026 in Review

Quantbot Technologies opened a new position in UroGen Pharma (URGN) in Q2 2026: 2,133 shares worth $78.5K. The stake represents ﹤0.01% of the portfolio and ranks #1529 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in URGN as recently as Q4 2025.

Quantbot Technologies first reported a position in URGN in Q1 2018 and has held it in 11 quarters since. The position peaked at $183K in Q2 2018. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Quantbot Technologies held 2,133 shares of UroGen Pharma worth $78.5K as of Q2 2026.
  • UroGen Pharma was a new Quantbot Technologies position in Q2 2026.
  • UroGen Pharma made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1529 holding.
  • Quantbot Technologies first reported a position in UroGen Pharma in Q1 2018 and has held it in 11 quarters since.
  • Quantbot Technologies's UroGen Pharma position peaked at $183K in Q2 2018.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.